期刊文献+

新型健康教育模式对精神分裂症患者事件相关电位P300的影响

Effects of neotype health education mode on the P300 of event- related potential with schizophrenia patients
下载PDF
导出
摘要 目的:探讨新型健康教育模式对精神分裂症患者事件相关电位P300的影响。方法:将120例首发精神分裂症住院患者随机分成两组,对其中60例实施新型健康教育模式(研究组),对照组采用传统式的健康教育。采用事件相关电位P300于治疗前和治疗后2个月时进行认知功能评定。结果:两组在健康教育治疗前事件相关电位P300各项指标差异无显著性意义(P〉0.05),健康教育治疗后两组事件相关电位成分中N2、P3波潜伏期较治疗前缩短,P3波幅增高,而研究组改变更为明显,两组差异存在统计学意义(P〈0.01)。结论:通过新型健康教育对精神分裂症患者事件相关电位P300的影响,证实其更有助于患者的认知功能康复。 Objective:To explore the effects of neotype health education mode on the P300 of event-related potential(ERP) with schizophrenia patients. Methods :120 inpatients of schizophrenia were randomly divided into two groups, New health education mode was applied to the study group and traditional health education mode was applied to the control group, Cognition assessment by ERPP300 were used for the two groups before treatment and two months after treatment. Results: There were no significant difference- between in the indexes of ERP of the two groups before treatment( P 〉 0.05 ) , After treatment, the latency of N2, P3 of ERP and the amplitude of P3 were shorter and higher than before treatment, but the study group changed more obviously, there were a significant difference in the two groups( P 〈 0.01 ). Conclusions: Through the effect of P300 of ERP with neotype health education mode on schizophrenia patients, It proved that the neotype health education mode can help to improve its cognition.
出处 《中国民康医学》 2009年第11期1302-1303,共2页 Medical Journal of Chinese People’s Health
关键词 新型健康教育 精神分裂症 事件相关电位P300 认知功能 Neotype health education mode Schizophrenia Event - related potential P300 Cognition
  • 相关文献

参考文献8

二级参考文献29

  • 1项志清,陈月敏,颜文伟.探索性眼球活动试验在精神分裂症诊断中的价值[J].上海精神医学,2004,16(5):263-266. 被引量:28
  • 2孙玉玺,吕东苗,徐静.精神分裂症住院患者康复期健康教育需求的研究[J].中国护理管理,2006,6(6):28-29. 被引量:11
  • 3张明岛 陈兴时.脑诱发电位学(第二版)[M].上海:上海科技教育出版社,1997.219-253.
  • 4Weickert TW, Goldberg TE, Marenco S, et al. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology, 2003,28 (12):2217-2218.
  • 5Brunnauer A, Geiger E, Laux G. Neuroleptics and cognition. Psychiatr Prax,2003 ,30 (Suppl 2): 106-109.
  • 6Heydebrand G,Weiser M,Rabinowitz J.Correlates of cognitive deficits infirst episode schizophrenia.Schizophr Res,2004,68(1):1-9.
  • 7Harvey PD, Napolitano JA, Mao L, et al. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. Int J Geriatr Psychiatry, 2003,18 (9): 820-829.
  • 8Chen PS, Yang YK, Su SF,et al. Correlation between scores on Continuous Performance Test and plasma concentration for schizophrenic patients on risperidone. Psychiatry Clin Neurosci,2004,58(2) :168-172.
  • 9Breier A. Cognitive deficit in schizophrenia and its neurochemical basis.Br J Psychiatry,1999, ( Suppl 37) :16-18.
  • 10Bilder RM, Goldman RS, Volavka J, et al. Neurocognitive effects of elozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry,2002,159(6) :1018-1028.

共引文献135

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部